Nevro Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
26,014.00
30,680.00
67,431.00
31,778.00
36,658.00
49,205
Depreciation, Depletion & Amortization
47.00
96.00
614.00
1,717.00
2,507.00
3,887
Other Funds
-
-
-
-
991.00
45,454
Funds from Operations
22,784.00
27,388.00
57,544.00
4,089.00
2,238.00
136
Changes in Working Capital
1,689.00
3,760.00
42,886.00
54,414.00
16,511.00
5,844
Net Operating Cash Flow
21,095.00
31,148.00
100,430.00
58,503.00
14,273.00
5,708
Capital Expenditures
55.00
625.00
5,008.00
3,368.00
4,327.00
Purchase/Sale of Investments
19,844.00
107,430.00
44,666.00
128,319.00
8,396.00
Net Investing Cash Flow
19,899.00
108,055.00
39,658.00
131,687.00
4,069.00
Issuance/Reduction of Debt, Net
-
19,500.00
-
101,737.00
-
Net Financing Cash Flow
47,785.00
152,081.00
122,827.00
145,164.00
11,199.00
Net Change in Cash
6,791.00
12,878.00
61,749.00
45,630.00
1,439.00
Free Cash Flow
21,150.00
31,773.00
105,438.00
61,871.00
18,600.00
Change in Capital Stock
47,785.00
132,581.00
122,827.00
43,427.00
12,190.00
Exchange Rate Effect
-
-
306.00
604.00
444.00

About Nevro

View Profile
Address
1800 Bridge Parkway
Redwood City California 94065
United States
Employees -
Website http://www.nevro.com
Updated 07/08/2019
Nevro Corp. engages in the provision of medical devices. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.